Abstract
Due to their daily involvement in mineral metabolism, nephrologists are often asked to consult on children with hypercalcemia. This might become even more pertinent when the hypercalcemia is associated with acute kidney injury and/or hypercalciuria and renal calcifications. The best way to assess the severity of hypercalcemia is by measurement of plasma ionized calcium, and if not available by adjusting serum total calcium to albumin concentration. The differential diagnosis of the possible etiologies of the disturbance in the mineral homeostasis starts with the assessment of serum parathyroid hormone concentration, followed by that of vitamin D metabolites in search of both genetic and acquired etiologies. Several tools are available to acutely treat hypercalcemia with the current main components being fluids, loop diuretics, and antiresorptive agents. This review will address the pathophysiologic mechanisms, clinical manifestations, and treatment modalities involved in hypercalcemia.
Similar content being viewed by others
References
Popovtzer MM (2003) Disorders of calcium, phosphorus, vitamin D and parathyroid hormone activity. In: Schrier RW (ed) Renal and electrolyte disorders, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 216–277
Davies JH, Shaw NJ (2012) Investigation and management of hypercalcaemia in children. Arch Dis Child 97(6):533–538
Blaine J, Chonchol M, Levi M (2015) Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol 10:1257–1272
Bushinsky DA, Monk RD (1998) Electrolyte quintet: Calcium. Lancet 352(9124):306–311
Goltzman D (2000) Approach to Hypercalcemia. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C (eds) Endotext. MDText.com, Inc., South Dartmouth, pp 1–44
Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U, Misselwitz J, Klaus G, Kuwertz-Bröking E, Fehrenbach H, Wingen AM, Güran T, Hoenderop JG, Bindels RJ, Prosser DE, Jones G, Konrad M (2011) Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 365:410–421
Molin A, Baudoin R, Kaufmann M, Souberbielle JC, Ryckewaert A, Vantyghem MC, Eckart P, Bacchetta J, Deschenes G, Kesler-Roussey G, Coudray N, Richard N, Wraich M, Bonafiglia Q, Tiulpakov A, Jones G, Kottler ML (2015) CYP24A1 mutations in a cohort of hypercalcemic patients: evidence for a recessive trait. J Clin Endocrinol Metab 100(10):E1343–E1352
Vahe C, Benomar K, Espiard S, Coppin L, Jannin A, Odou MF, Vantyghem MC (2017) Diseases associated with calcium-sensing receptor. Orphanet J Rare Dis. https://doi.org/10.1186/s13023-017-0570-z
Riccardi D, Valenti G (2016) Localization and function of the renal calcium-sensing receptor. Nature 12:414–425
Tagiyev A, Demirbilek H, Tavil B, Buyukyilmaz G, Gumruk F, Cetin M (2016) Severe hypercalcemia in a child with acute lymphoblastic leukemia relapse: successful management with combination of calcitonin and bisphosphonate. J Pediatr Hematol Oncol 38(3):232–234
Davies JH (2015) Approach to the child with hypercalcaemia. Endocr Dev 28:101–118
Trehan A, Cheetham T, Bailey S (2009) Hypercalcemia in acute lymphoblastic leukemia: an overview. J Pediatr Hematol Oncol 31(6):424–427
Reynolds BC, Cheetham TD (2015) Bones, stones, moans and groans: hypercalcaemia revisited. Arch Dis Child Educ Pract Ed 100(1):44–51
Camirand A, Goltzman D, Gupta A, Kaouass M, Panda D, Karaplis A (2016) The role of parathyroid hormone-related protein (PTHrP) in osteoblast response to microgravity: mechanistic implications for osteoporosis development. PLoS One 11(7):xxx
Lean JM, Matsuo K, Fox SW, Fuller K, Gibson FM, Draycott G, Wani MR, Bayley KE, Wong BR, Choi Y, Wagner EF, Chambers TJ (2000) Osteoclast lineage commitment of bone marrow precursors through expression of membrane-bound TRANCE†. Bone 27(1):29–40
Park HJ, Choi EJ, Kim JK (2016) A successful treatment of hypercalcemia with zoledronic acid in a 15-year-old boy with acute lymphoblastic leukemia. Ann Pediatr Endocrinol Metab 21(2):99–104
Rodd C, Goodyer P (1999) Hypercalcemia of the newborn: etiology, evaluation, and management. Pediatr Nephrol 13(6):542–547
Tosur M, Patel KN, Swischuk LE, Lee PD (2017) Incidental Hypercalcemia caused by primary hyperparathyroidism with rapid progression to renal complications in a child. Clin Pediatr. https://doi.org/10.1177/0009922816685822
Roizen J, Levine MA (2012) Primary hyperparathyroidism in children and adolescents. J Chin Med Assoc 75(9):425–434
Magalhães PK, Antonini SR, de Paula FJ, de Freitas LC, Maciel LM (2011) Primary hyperparathyroidism as the first clinical manifestation of multiple endocrine neoplasia type 2A in a 5-year-old child. Thyroid 21(5):547–550
Hechanova LA, Sadjadi SA (2014) Severe hypercalcemia complicating recovery of acute kidney injury due to rhabdomyolysis. Am J Case Rep 14(15):393–396
Alon U, Lovell HB, Donaldson DL (1992) Nephrocalcinosis, hyperparathyroidism and renal failure in familial hypophosphatemic rickets. Clin Pediatr 21:180–183
Yavropoulou MP, Kotsa K, Gotzamani Psarrakou A, Papazisi A, Tranga T, Ventis S, Yovos JG (2010) Cinacalcet in hyperparathyroidism secondary to X-linked hypophosphatemic rickets: case report and brief literature review. Hormones 9:274–278
Nesbit MA, Hannan FM, Howles SA, Babinsky VN, Head RA, Cranston T, Rust N, Hobbs MR, Heath H 3rd, Thakker RV (2013) Mutations affecting G-protein subunit α11 in hypercalcemia and hypocalcemia. N Engl J Med 368:2476–2486
Nesbit MA, Hannan FM, Howles SA, Reed AA, Cranston T, Thakker CE, Gregory L, Rimmer AJ, Rust N, Graham U, Morrison PJ, Hunter SJ, Whyte MP, McVean G, Buck D, Thakker RV (2013) Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3. Nat Genet 13(45):93–97
Alon US, VanDeVoorde RG (2010) Beneficial effect of cinacalcet in a child with familial hypocalciuric hypercalcemia. Pediatr Nephrol 25:1747–1750
Wilhelm-Bals A, Parvex P, Magdelaine C, Girardin E (2012) Successful use of bisphosphonate and calcimimetic in neonatal severe primary hyperparathyroidism. Pediatrics 129:e812–e816
Powell BR, Blank E, Benda G, Buist NR (1993) Neonatal hyperparathyroidism and skeletal demineralization in an infant with familial hypocalciuric hypercalcemia. Pediatrics 91(1):144–145
Glass EJ, Barr DG (1981) Transient neonatal hyperparathyroidism secondary to maternal pseudohypoparathyroidism. Arch Dis Child 56(7):565–568
Savani RC, Mimouni F, Tsang RC (1993) Maternal and neonatal hyperparathyroidism as a consequence of maternal renal tubular acidosis. Pediatrics 91(3):661–663
Jacobs TP, Bilezikian JP (2005) Clinical review: rare causes of hypercalcemia. J Clin Endocrinol Metab 90(11):6316–6322
Beckman MJ, Johnson JA, Goff JP, Reinhardt TA, Beitz DC, Horst RL (1995) The role of dietary calcium in the physiology of vitamin D toxicity: excess dietary vitamin D3 blunts parathyroid hormone induction of kidney 1-hydroxylase. Arch Biochem Biophys 319(2):535–539
Kara C, Çetinkaya S, Gündüz S, Can Yılmaz G, Aycan Z, Aydın M (2016) Efficacy and safety of pamidronate in children with vitamin D intoxication. Pediatr Int 58(7):562–568
Fencl F, Bláhová K, Schlingmann KP, Konrad M, Seeman T (2013) Severe hypercalcemic crisis in an infant with idiopathic infantile hypercalcemia caused by mutation in CYP24A1 gene. Eur J Pediatr 172(1):45–49
Bosch X (1998) Hypercalcemia due to endogenous overproduction of active vitamin D in identical twins with cat-scratch disease. JAMA 279(7):532–534
Monkawa T, Yoshida T, Hayashi M, Saruta T (2000) Identification of 25-hydroxyvitamin D3 1alphahydroxylase gene expression in macrophages. Kidney Int 58(2):559–568
Sebestyen VanSickle J, Srivastava T, Alon US (2017) Life-threatening hypercalcemia during prodrome of Pneumocystis jiroveci pneumonia in an immunocompetent infant. Glob Pediatr Health 3:1–4
Sfeir J, Zogala R, Popii V (2017) Hypercalcemia in necrobiotic xanthogranuloma: first reported case and insight into treatment. J Bone Miner Res 32(4):784–787
Bency R, Roger SD, Elder GJ (2011) Hypercalcaemia as a prodromal feature of indolent Pneumocystis jivorecii after renal transplantation. Nephrol Dial Transplant 26(5):1740–1742
Hajji K, Dalle F, Harzallah A, Tanter Y, Rifle G, Mousson C (2009) Vitamin D metabolite-mediated hypercalcemia with suppressed parathormone concentration in Pneumocystis jiroveci pneumonia after kidney transplantation. Transplant Proc 41(8):3320–3322
Kallas M, Green F, Hewison M, White C, Kline G (2010) Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review. J Clin Endocrinol Metab 95(7):3111–3117
Finne PH, Sanderud J, Aksnes L, Bratlid D, Aarskog D (1988) Hypercalcemia with increased and unregulated 1,25-dihydroxyvitamin D production in a neonate with subcutaneous fat necrosis. J Pediatr 112(5):792–794
Martínez de Zabarte Fernández JM, Laliena Aznar S, Corella Aznar E (2016) Subcutaneous fat necrosis and persistent hypercalcaemia in a newborn treated with therapeutic neonatal hypothermia. Arch Argent Pediatr 114(1):e13–e16
Hazza IA, Ghandour MS, Almardini RI, Haddad RE, Salaita GM (2014) Hypercalcemia, hypercalciuria and nephrocalcinosis in a breast-fed term newborn: a rare presentation. Saudi J Kidney Dis Transpl 25(4):849–853
Kimura S, Nose O, Seino Y, Harada T, Kanaya S, Yabuuchi H, Itakura T, Takagi Y, Okada A (1986) Effects of alternate and simultaneous administrations of calcium and phosphorus on calcium metabolism in children receiving total parenteral nutrition. J Parenter Enter Nutr 10(5):513–516
Schlingmann KP, Ruminska J, Kaufmann M, Dursun I, Patti M, Kranz B, Pronicka E, Ciara E, Akcay T, Bulus D, Cornelissen EA, Gawlik A, Sikora P, Patzer L, Galiano M, Boyadzhiev V, Dumic M, Vivante A, Kleta R, Dekel B, Levtchenko E, Bindels RJ, Rust S, Forster IC, Hernando N, Jones G, Wagner CA, Konrad M (2016) Autosomal-recessive mutation in SLC34A1 encoding sodium-phosphate cotransporter 2A cause idiopathic infantile hypercalcemia. J Am Soc Nephrol 27:604–614
Sargent JT, Smith OP (2010) Haematological emergencies managing hypercalcaemia in adults and children with haematological disorders. Br J Haematol 149(4):465–477
Çelik E, Özdemir GN, Tüysüz G, Taştan Y, Çam H, Celkan T (2014) A child presenting with hypercalcemia. Turk Pediatri Ars 49(1):81–83
Kolyva S, Efthymiadou A, Gkentzi D, Karana-Ginopoulou A, Varvarigou A (2014) Hypercalcemia and osteolytic lesions as presenting symptoms of acute lymphoblastic leukemia in childhood. The use of zoledronic acid and review of the literature. J Pediatr Endocrinol Metab 27(3-4):349–354
Dufek S, Seidl R, Schmook M, Arbeiter K, Müller-Sacherer T, Heindl-Rusai K (2015) Intracranial hypertension in siblings with infantile hypercalcemia. Neuropediatrics 46(1):49–51
Kodous N, Filler G, Sharma AP, Van Hooren TA (2015) PTHrP-related Hypercalcaemia in infancy and congenital anomalies of the kidney and urinary tract (CAKUT). Can J Kidney Health Dis 11(2):21
Srivastava T, Kats A, Martin TJ, Pompolo S, Alon US (2011) Parathyroid hormone-related protein-mediated hypercalcemia in children with benign mesoblastic nephroma. Pediatr Nephrol 26:799–803
Mune T, Katakami H, Kato Y, Yasuda K, Matsukura S, Miura K (1993) Production and secretion of parathyroid hormone-related protein in pheochromocytoma: participation of an alpha-adrenergic mechanism. J Clin Endocrinol Metab 76(3):757–762
Sindhar S, Lugo M, Levin MD, Danback JR, Brink BD, Yu E, Dietzen DJ, Clark AL, Purgert CA, Waxler JL, Elder RW, Pober BR, Kozel BA (2016) Hypercalcemia in patients with Williams–Beuren syndrome. J Pediatr 178:254–260
Helfrich A, Philla KQ (2015) Late-onset hypercalcemia in Williams–Beuren syndrome: importance of early and frequent screening and intervention. J Pediatr Endocr Met 28:425–428
Whyte MP (2016) Hypophosphatasia—aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 12(4):233–246
Nampoothiri S, Fernández-Rebollo E, Yesodharan D, Gardella TJ, Rush ET, Langman CB, Jüppner H (2016) Jansen metaphyseal chondrodysplasia due to heterozygous H223R-PTH1R mutations with or without overt hypercalcemia. J Clin Endocrinol Metab 101(11):4283–4289
Vyas AK, White NH (2011) Case of hypercalcemia secondary to hypervitaminosis a in a 6-year-old boy with autism. Case Rep Endocrinol 2011:424712
Barker ME, Blumsohn A (2003) Is vitamin a consumption a risk factor for osteoporotic fracture? Proc Nutr Soc 62(4):845–850
Safi KH, Filbrun AG, Nasr SZ (2014) Hypervitaminosis a causing hypercalcemia in cystic fibrosis. Case report and focused review. Ann Am Thorac Soc 11(8):1244–1247
Grinsell MM, Norwood VF (2009) At the bottom of the differential diagnosis list: unusual causes of pediatric hypertension. Pediatr Nephrol 24(11):2137–2146
Cano-Torres EA, González-Cantu A, Hinojosa-Garza G, Castilleja-Leal F (2016) Immobilization induced hypercalcemia. Clin Cases Miner Bone Metab 13(1):46–47
Vyas N, Kaminski B, MacLeish S (2016) A rare case report of immobility-induced Hypercalcemia in an infant. Pediatrics. https://doi.org/10.1542/peds.2015-0879
Auron A, Alon US (2005) Resolution of medullary nephrocalcinosis in children with metabolic bone disorders. Pediatr Nephrol 20(8):1143–1145
Bettinelli A, Ciarmatori S, Cesareo L, Tedeschi S, Ruffa G, Appiani AC, Rosini A, Grumieri G, Mercuri B, Sacco M, Leozappa G, Binda S, Cecconi M, Navone C, Curcio C, Syren ML, Casari G (2000) Phenotypic variability in Bartter syndrome type I. Pediatr Nephrol 14:940–945
Gross I, Siedner-Weintraub Y, Simckes A, Gillis D (2015) Antenatal Bartter syndrome presenting as hyperparathyroidism with hypercalcemia and hypercalciuria: a case report and review. J Pediatr Endocrinol Metab 28(7-8):943–946
Pressey JG, Kelly DR, Hawthorne HT (2013) Successful treatment of preadolescents with small cell carcinoma of the ovary hypercalcemic type. J Pediatr Hematol Oncol 35(7):566–569
Drummond KN, Michael AF, Ulstrom RA, Good RA (1964) The blue diaper syndrome: familial hypercalcemia with nephrocalcinosis and indicanuria; a new familial disease, with definition of the metabolic abnormality. Am J Med 37:928–948
Kulpiya A, Mahachoklertwattana P, Pakakasama S, Hongeng S, Poomthavorn P (2012) Hypercalcemia and altered biochemical bone markers in post-bone marrow transplantation osteopetrosis: a case report and literature review. Pediatr Transplant 16(5):E140–E145
Saarela T, Simila S, Koivisto M (1995) Hypercalcemia and nephrocalcinosis in patients with congenital lactase deficiency. J Pediatr 127(6):920–923
Makaya T, Chatterjee S, Arundel P, Bevan C, Wright NP (2013) Severe hypercalcemia in diabetic ketoacidosis: a case report. Diabetes Care 36(4):e44
Lietman SA, Germain-Lee EL, Levine MA (2010) Hypercalcemia in children and adolescents. Curr Opin Pediatr 22(4):508–515
Tran HA, Song S, Crock PA, Mattes J, Howard K (2009) The a, B, C, D of hypercalcaemia in Down syndrome. BMJ Case Rep 9:2009
Hak EB, Crill CM, Bugnitz MC, Mouser JF, Chesney RW (2005) Increased parathyroid hormone and decreased calcitriol during neonatal extracorporeal membrane oxygenation. Intensive Care Med 31(2):264–270
Abdelmogheth AA, El-Baroudy I, Al-Yaaruby S (2013) Plasmapheresis-induced hypercalcaemia. Sultan Qaboos Univ Med J 13(1):147–151
Lodefalk M, Frykholm C, Esbjörner E, Ljunggren Ö (2016) Hypercalcaemia in a patient with 2p13.2-p16.1 duplication. Horm Res Paediatr 85(3):213–218
Ahn SW, Kim TY, Lee S, Jeong JY, Shim H, Han YM, Choi KE, Shin SJ, Yoon HE (2016) Adrenal insufficiency presenting as hypercalcemia and acute kidney injury. Int Med Case Rep J 9:223–226
De Rechter S, Levtchenko E, Evenepoel P, Mekahli D (2016) The case | Hypercalcemia in a child with chronic kidney disease. Kidney Int 90(1):233–234
Procino G, Mastrofrancesco L, Mira A, Tamma G, Carmosino M, Emma F, Svelto M, Valenti G (2008) Aquaporin 2 and apical calcium-sensing receptor: new players in polyuric disorders associated with hypercalciuria. Semin Nephrol 28(3):297–305
Khanna A (2006) Acquired nephrogenic diabetes insipidus. Semin Nephrol 26(3):244–248
Auron A, Tal L, Srivastava T, Alon US (2009) Reversal of hypercalcemic acute kidney injury by intravenous bisphosphonates. Pediatr Nephrol 24:613–617
Mulder JE, Bilezikian JP (2001) Acute management of hypercalcemia. In: Bilezikian JP, Marcus R, Levine MD (eds) The parathyroids, basic and clinical concepts, 2nd edn. Academic Press, San Diego, pp 729–741
Alon US, Scagliotti D, Garola RE (1994) Nephrocalcinosis and nephrolithiasis in infants with congestive heart failure treated with furosemide. J Pediatri 125:149–151
Alon U, Berkowitz D, Berant M (1992) Idiopathic infantile hypercalcemia: rapid response to treatment with calcitonin. Child Nephrol Urol 12:47–50
Sebestyen JF, Srivastava T, Alon US (2012) Bisphosphonates use in children. Clin Pediatr 51(11):1011–1024
Nguyen M, Boutignon H, Mallet E, Linglart A, Guillozo H, Jehan F, Garabedian M (2010) Infantile hypercalcemia and hypercalciuria: new insights into a vitamin D- dependent mechanism and response to ketoconazole treatment. J Pediatr 125(2):296–302
Timmers HJ, Karperien M, Hamdy NA, de Boer H, Hermus AR (2006) Normalization of serum calcium by cinacalcet in a patient with hypercalcaemia due to a de novo inactivating mutation of the calcium-sensing receptor. J Intern Med 260(2):177–182
Platt C, Inward C, McGraw M, Dudley J, Tizard J, Burren C, Saleem MA (2012) Middle-term use of cinacalcet in paediatric dialysis patients. Pediatr Nephrol 25(1):143–148
Shroff R, Beringer O, Rao K, Hofbauer LC, Schulz A (2012) Denosumab for post-transplantation hypercalcemia in osteopetrosis. N Engl J Med 367(18):1766–1767
Acknowledgements
We would like to thank Ms. Andrea Fontana for her administrative assistance. This work was supported by the Sam and Helen Kaplan Research Fund in Pediatric Nephrology and the Eric McClure Research Fund in Bone and Mineral Metabolism.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Answers to questions:
1 d
2 a
3 c
4 d
5 a
Rights and permissions
About this article
Cite this article
Auron, A., Alon, U.S. Hypercalcemia: a consultant’s approach. Pediatr Nephrol 33, 1475–1488 (2018). https://doi.org/10.1007/s00467-017-3788-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-017-3788-z